← Back
$ROIV All transactions

Roivant Sciences Ltd.

J

$ Value

$0

Shares

6,837,266

Price

$0

Filed

Jun 27

Insider

Name

MANCHESTER KEITH S

Title

CIK

0001244828

Roles

Director

Transaction Details

Transaction Date

2025-06-25

Code

J

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. (together, "QVT Roiv"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd., a related fund, contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. | The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT QVT FIC (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. | Includes shares reporting person received as part of the distribution described in (1) above which is exempted under Rule 16a-9 and/or Rule 16a-13 as a change in form of beneficial ownership and (i) an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy (the "Equity Plan"), which vested on September 12, 2024 and (ii) an annual award of restricted stock units with respect to RSU granted pursuant to the Equity Plan, which is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date.

Filing Info

Accession No.

0000950170-25-090994

Form Type

4

Issuer CIK

0001635088

MANCHESTER KEITH S's History

Date Ticker Type Value
2025-06-25 ROIV J $0
2025-06-25 ROIV J $0
2025-06-25 ROIV J $0
2025-06-25 ROIV J $0

Other Insiders at ROIV (90d)

Insider Bought Sold Last
MOMTAZEE JAMES C 2026-04-17
Fitzgerald Meghan $1.9M 2026-03-26
Oren Ilan 2026-04-17
Torti Frank
President and Vant Chair
2026-03-31
Sukhatme Mayukh
President & CIO
2026-03-31
Gline Matthew
CEO
$8.4M 2026-04-16
Venker Eric
President & Immunovant CEO
$5.9M 2026-04-20
Epperly Melissa B, 2026-04-17
Pulik Richard
CFO
2026-04-20
Humes Jennifer
Chief Accounting Officer
$384K 2026-04-20